Predictive Value of TG/HDL-C, TyG, and TyG-BMI Indices for Pancreatic Fistula Following Pancreaticoduodenectomy: A Single-Center Retrospective Cohort Study
This single-center retrospective cohort study of 602 patients demonstrates that the TG/HDL-C, TyG, and TyG-BMI indices are independent predictors of clinically relevant postoperative pancreatic fistula following pancreaticoduodenectomy, with the TyG-BMI index showing the strongest risk gradient and greatest potential for preoperative risk stratification.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Surgery on the pancreas is one of the most delicate operations a surgeon can perform. The organ sits deep in the abdomen, and when a surgeon must remove a portion of it, often to treat a tumor, they must reconnect the remaining tissue to the digestive system. This connection is a fragile junction, and if it fails, a serious complication called a pancreatic fistula can occur. In this condition, digestive enzymes leak out of the new connection, causing infection, bleeding, and a long, difficult recovery. For decades, surgeons have known that the physical texture of the pancreas is the biggest clue to whether this leak will happen. A pancreas that feels soft and fatty is much more likely to leak than a firm, fibrous one. However, feeling the organ with a hand only happens during the surgery itself, leaving the medical team blind to the risk before the patient even enters the operating room.
Scientists have long suspected that the body's ability to process sugar and fat, known as insulin resistance, is linked to this soft, fatty texture. When the body struggles to manage these nutrients, fat can build up inside the pancreas, turning it soft and prone to failure. Researchers have developed simple ways to measure this struggle using standard blood tests for sugar and fat, combined with a patient's height and weight. A new study from the First Affiliated Hospital of Xinjiang Medical University set out to see if these simple blood-based numbers could predict who would suffer from a leak after surgery, potentially allowing doctors to prepare for the worst before the first cut is made.
The researchers looked back at the records of 602 patients who had undergone this major pancreatic surgery between 2018 and 2025. They divided the group into two categories: those who healed without a major leak and those who developed a clinically relevant fistula, a severe form of the complication that required extra medical intervention. By comparing the blood work and body measurements of these two groups, the team tested three different ways of calculating insulin resistance. One method looked at the ratio of triglycerides to a specific type of good cholesterol. Another combined fasting blood sugar with triglycerides. The third multiplied that sugar-fat combination by the patient's body mass index.
The study found that all three of these simple calculations were indeed independent predictors of a leak. Patients with higher numbers in any of these categories were significantly more likely to develop a fistula. However, the way these numbers predicted risk was not the same for all three. The first method, which looked at the balance between triglycerides and good cholesterol, showed a sudden jump in danger. For most people, even if this number was slightly high, the risk remained low. But once the number crossed a specific high threshold, the risk of a leak surged dramatically, as if a switch had been flipped. This suggests that mild fat metabolism issues are manageable, but severe ones create a perfect storm for surgical failure.
The second method, which combined sugar and fat levels without considering body weight, showed a steady, straight-line increase in risk. As the number went up, the chance of a leak went up in a predictable, step-by-step fashion. This indicated that the severity of the metabolic struggle itself was a continuous threat to the healing process. The third method, which included body weight in the calculation, proved to be the most powerful predictor of all. It showed a pattern of exponential growth. For patients with lower scores, the risk was minimal, but once their score passed a certain point, the danger rose sharply and steeply. Patients in the highest group for this measure were more than eight times as likely to develop a fistula compared to those in the lowest group.
The researchers concluded that while all three blood tests offer valuable insight, the one that combines sugar, fat, and body weight is the most effective tool for identifying high-risk patients before surgery. This index captures the combined danger of being overweight and having metabolic issues, a combination that seems to soften the pancreas and weaken its ability to heal. Because these tests rely on routine blood work and a simple height and weight measurement, they are easy to perform in any hospital. The findings suggest that doctors could use this information to identify patients who need extra care, perhaps by adjusting their diet or medication before the operation, or by using more careful surgical techniques to protect the fragile connection. While the study was conducted at a single hospital and looked at past records, the results provide a clear, evidence-based path toward preventing one of the most dangerous complications of pancreatic surgery.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.